The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Racial disparities and survival outcome of patients with locally advanced cervix cancer in the international randomised phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
 
Yeh Chen Lee
Speakers' Bureau - AstraZeneca
Research Funding - BeiGene (Inst)
 
Tara Castellano
No Relationships to Disclose
 
Tashanna K. N. Myers
Consulting or Advisory Role - Immunogen; Immunogen
 
Elizabeth H Barnes
No Relationships to Disclose
 
Dana Meredith Chase
Honoraria - AstraZeneca/Merck; Eisai; Genmab/Seattle Genetics; Immunogen; Merck; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca/Merck; Immunogen; Tesaro/GSK
Speakers' Bureau - AstraZeneca/Merck; Eisai; Genmab/Seattle Genetics; Immunogen; Tesaro/GSK
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Tesaro/GSK
 
Colleen McCormick
No Relationships to Disclose
 
Katrina Diamante
No Relationships to Disclose
 
Catherine M. Shannon
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Lilly; Merck sharp and Dohme; Roche
Speakers' Bureau - Amgen; AstraZeneca; Gilead Sciences; GlaxoSmithKline; merk sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
 
Warner King Huh
No Relationships to Disclose
 
Jayanthi Sivasothy Lea
No Relationships to Disclose
 
Joan L. Walker
Honoraria - Merck; Pieces Tech; Pieces Tech
Research Funding - Genentech; Pieces Tech (Inst); us biotest
 
William Small
Honoraria - Carl Zeiss Meditec
Consulting or Advisory Role - Novocure
Travel, Accommodations, Expenses - Carl Zeiss Meditec
 
Katherine Miller
No Relationships to Disclose
 
Geetha Govindarajulu
No Relationships to Disclose
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Acrivon Therapeutics; Adaptimmune; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; HenRui; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Panavance Therapeutics; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics; Verastem; Zentalis
Consulting or Advisory Role - Adaptimmune; Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; HenRui; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Laekna Health Care; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Panavance Therapeutics; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics; Verastem; Zentalis
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Martin R Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tilray (Inst)
 
Kathleen N. Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Great Debates and Updates; Physicans' Education Resource; Prime Oncology; Research To Practice
Consulting or Advisory Role - AADi; aadi; Alkermes (Inst); AstraZeneca; Blueprint Medicines (Inst); Caris Life Sciences; Clovis Oncology; Duality Biologics (Inst); Eisai; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); Hengrui Pharmaceutical; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Merck; Mereo BioPharma; Mersana (Inst); Myriad Genetics; Novartis; Novartis/Pfizer; Onconova Therapeutics; OncXerna Therapeutics; Regeneron; VBL Therapeutics; Verastem/Pharmacyclics; zentalis
Research Funding - Agenus (Inst); Amgen (Inst); artios (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo/Lilly (Inst); Genentech (Inst); Immunocore (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline
Other Relationship - GOG Partners (Inst)
 
Linda R. Mileshkin
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - Roche
 
Victoria Lin Bae-Jump
Consulting or Advisory Role - Eisai
Research Funding - Chimerix (Inst); Genentech (Inst); Merck (Inst)